T. Rowe director granted dividend shares
PRICE T ROWE GROUP INC director Robert F. MacLellan acquired 206.3598 shares of Common Stock as a fully vested grant under the company’s 2017 Non-Employee Director Equity Plan, tied to dividends on the stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
PRICE T ROWE GROUP INC director Robert F. MacLellan acquired 206.3598 shares of Common Stock as a fully vested grant under the company’s 2017 Non-Employee Director Equity Plan, tied to dividends on the stock. The shares were credited as dividend reinvestment, bringing his direct holdings to 52,965.8316 shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 206.3598 | $89.03 | $18K |
Footnotes (1)
- F1. This is pursuant to the T. Rowe Price Group, Inc. 2017 Non-Employee Director Equity Plan with respect to dividends declared by the issuer on it's Common Stock. These shares were credited as fully-vested dividend reinvestment shares.
Key Figures
Key Terms
2017 Non-Employee Director Equity Plan financial
Common Stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did TROW director Robert F. MacLellan report on this Form 4?
Was the TROW Form 4 transaction a market buy or a compensation grant?
What is the T. Rowe Price 2017 Non-Employee Director Equity Plan mentioned in MacLellan’s filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.